Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile.[A179098] Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia.[A179098] Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.[L6582][L6583][L7309][L7312]
Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache
Aleve
Medique Mediproxen
Sinus and Cold D
Comfort Pac with Naproxen
Calmadol Pain Reliever
Naprosyn 375mg Tablets
Flanax Pain Relief Kit
Naproxen Sodium
CAREALL Naproxen
PREVACID NapraPAC 500
First Aid Direct Naproxen Sodium
Berkley and Jensen Naproxen Sodium
Naproxen Sodium DS
Healthy Accents Naproxen Sodium
NaproPax
Naprosyn 500 Mg Tablets
Aleve PM
Naproxen Pain Relief
Nu-napro-NA
Nu-napro-NA DS
Naproxen - 250
Ntp-naproxen EC
Smart Sense Naproxen Sodium
Apo-napro-NA DS
Naprosyn 250mg
Ratio-naproxen E
Teva-naproxen
Nx 12 Hour
Naprosyn E Tab 375mg
Leader Sinus and Cold D
Naproxen
Suvexx
Naproxen Delayed-release
Proxen Np 660
Dg Health Naproxen Sodium
Aleve Easy Open Arthritis Cap
All Day Pain Relief Back and Muscle Pain
CareOne Naproxen Sodium
NaproxenPax
Nu-naprox Tab 500mg
PREVACID NapraPAC 375
Equate All Night Pain Relief
Anaprox DS
Pain Zero
Indication
Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682